Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China flag China · Delayed Price · Currency is CNY
10.09
-0.18 (-1.75%)
Nov 13, 2026, 3:04 PM CST

SHE:300705 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,8893,1082,9302,6912,3251,627
Other Revenue
2.792.791.151.020.890.82
2,8923,1112,9312,6932,3261,628
Revenue Growth
-5.28%6.15%8.85%15.75%42.92%66.40%
Cost of Revenue
1,052849.11790.88621.79522.52365.47
Gross Profit
1,8402,2622,1402,0711,8041,262
Selling, General & Admin
1,2561,4701,3311,4051,285878.31
Research & Development
160.78218.41245.97254.12201.26146.26
Other Operating Expenses
45.2528.725.1528.4725.8721.04
Operating Expenses
1,4621,7181,5981,6961,5251,051
Operating Income
377.48543.69541.62375.12278.84211.22
Interest Expense
-4.56-14.99-18.63-11.06-18.42-16.01
Interest & Investment Income
0.472.468.567.676.85.82
Currency Exchange Gain (Loss)
-0.06-0.06-0.26-0.42-0.27-0.14
Other Non Operating Income (Expenses)
-41.37-23.8-0.58-0.29-0.24-0.19
EBT Excluding Unusual Items
331.97507.31530.71371.02266.71200.7
Gain (Loss) on Sale of Investments
-2.33-0.96----
Gain (Loss) on Sale of Assets
-0.030.05-0.03-0.02
Asset Writedown
-10.49-4.22-1.92-1.46-1.3-1.9
Other Unusual Items
35.224.1843.432.5724.8127.38
Pretax Income
354.32526.36572.19402.16290.22226.19
Income Tax Expense
59.7556.3359.8233.920.5221.94
Earnings From Continuing Operations
294.57470.04512.38368.26269.7204.25
Minority Interest in Earnings
11.792.78----
Net Income
306.36472.82512.38368.26269.7204.25
Net Income to Common
306.36472.82512.38368.26269.7204.25
Net Income Growth
-34.68%-7.72%39.13%36.55%32.05%148.29%
Shares Outstanding (Basic)
488493488478460461
Shares Outstanding (Diluted)
488498493504460461
Shares Change
-4.65%1.02%-2.34%9.55%-0.15%0.13%
EPS (Basic)
0.630.961.050.770.590.44
EPS (Diluted)
0.630.951.040.730.590.44
EPS Growth
-31.50%-8.65%42.47%24.64%32.24%147.98%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
134.44-5.83348.54.37-144.3964.94
Free Cash Flow Per Share
0.28-0.010.710.01-0.310.14
Dividend Per Share
0.4000.4000.3130.2290.1690.133
Dividend Growth
27.81%27.81%36.49%36.00%26.67%507.76%
Gross Margin
63.62%72.70%73.01%76.91%77.54%77.55%
Operating Margin
13.05%17.48%18.48%13.93%11.99%12.98%
Profit Margin
10.60%15.20%17.48%13.68%11.59%12.55%
Free Cash Flow Margin
4.65%-0.19%11.89%0.16%-6.21%3.99%
EBITDA
517.21664.19636.49446.5338.49264.8
EBITDA Margin
17.89%21.35%21.72%16.58%14.55%16.27%
D&A For EBITDA
139.73120.594.8771.3759.6453.58
EBIT
377.48543.69541.62375.12278.84211.22
EBIT Margin
13.05%17.48%18.48%13.93%11.99%12.98%
Effective Tax Rate
16.86%10.70%10.45%8.43%7.07%9.70%
Revenue as Reported
842.863,1112,9312,6932,3261,628
Advertising Expenses
-39.6479.6473.0177.4128.51